Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212873892> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4212873892 abstract "Introduction: Hepatocellular Carcinoma (HCC) is considered one of the deadliest cancers which grow rapidly worldwide. Fucoxanthin can be acquired from edible brown seaweeds, reported that fucoxanthin has numerous physiological functions and biological abilities, and various medicinal properties. Aim: To evaluate the anti-carcinogenic efficiency of fucoxanthin against the Human Hepatoma Cell Line (HepG2). Materials and Methods: This in-vitro examination and research was carried from June 2018 to August 2018, at Alagappa University, Karaikudi, Tamil Nadu, India. Fucoxanthin at different concentrations was taken to demonstrate its antiproliferative potential and its cytotoxic effect. In this present examination, based on the outcome of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl2H-tetrazolium bromide (MTT) assay, 80 µM and 100µM were chosen for further in-vitro studies. It was noted that remarkable leakage of Lactate Dehydrogenase (LDH) and a noteworthy decrease in the Glutathione (GSH) content of 80µ M and 100µM of fucoxanthin treated HepG2 cells. Under light and fluorescence microscopic examination, there was a significant reduction in cell growth and cell proliferation in the fucoxanthin-treated HepG2 cells. Data were presented as the mean±standard deviation. The one-way analysis of variance (ANOVA) and Tukey’s multiple comparison method were used to find the level of significance. Results: The human HepG2 to be studied and analysed were divided into group I: control group; group II: comprising those cells treated with fucoxanthin in concentration of 80 µM; group III: comprising those cells treated with fucoxanthine in concentration of 100 µM. The results of the MTT assay put forward that fucoxanthin has the cytotoxic and anti-proliferative potential against HepG2 further fucoxanthin significantly alter the marker enzymes level (p-value <0.05). The therapeutic efficiency of fucoxanthin might be due to the antioxidant effect of the bioactive compound. In this present investigation, the results of in-vitro studies, fucoxanthin strongly put forward that it has potential anticarcinogenic efficacy against the hepatic tumour (p-value <0.05). Conclusion: The results of this analysis undoubtedly symbolise that fucoxanthin has anti-oxidant activity and anti-carcinogenic efficacy against primary liver cancer HCC. Due to their therapeutic efficacy, may be considered as an excellent candidate against HCC." @default.
- W4212873892 created "2022-02-24" @default.
- W4212873892 creator A5023764746 @default.
- W4212873892 creator A5074420257 @default.
- W4212873892 creator A5075730215 @default.
- W4212873892 date "2022-01-01" @default.
- W4212873892 modified "2023-09-25" @default.
- W4212873892 title "Anticarcinogenic Efficacy of Fucoxanthin on HepG2 Cell Lines" @default.
- W4212873892 doi "https://doi.org/10.7860/jcdr/2022/49462.16007" @default.
- W4212873892 hasPublicationYear "2022" @default.
- W4212873892 type Work @default.
- W4212873892 citedByCount "1" @default.
- W4212873892 countsByYear W42128738922022 @default.
- W4212873892 crossrefType "journal-article" @default.
- W4212873892 hasAuthorship W4212873892A5023764746 @default.
- W4212873892 hasAuthorship W4212873892A5074420257 @default.
- W4212873892 hasAuthorship W4212873892A5075730215 @default.
- W4212873892 hasBestOaLocation W42128738921 @default.
- W4212873892 hasConcept C153911025 @default.
- W4212873892 hasConcept C181199279 @default.
- W4212873892 hasConcept C185592680 @default.
- W4212873892 hasConcept C202751555 @default.
- W4212873892 hasConcept C2777318727 @default.
- W4212873892 hasConcept C2780783641 @default.
- W4212873892 hasConcept C2781231385 @default.
- W4212873892 hasConcept C28781525 @default.
- W4212873892 hasConcept C31903555 @default.
- W4212873892 hasConcept C33070731 @default.
- W4212873892 hasConcept C54355233 @default.
- W4212873892 hasConcept C55493867 @default.
- W4212873892 hasConcept C556039675 @default.
- W4212873892 hasConcept C62112901 @default.
- W4212873892 hasConcept C71924100 @default.
- W4212873892 hasConcept C81885089 @default.
- W4212873892 hasConcept C86803240 @default.
- W4212873892 hasConceptScore W4212873892C153911025 @default.
- W4212873892 hasConceptScore W4212873892C181199279 @default.
- W4212873892 hasConceptScore W4212873892C185592680 @default.
- W4212873892 hasConceptScore W4212873892C202751555 @default.
- W4212873892 hasConceptScore W4212873892C2777318727 @default.
- W4212873892 hasConceptScore W4212873892C2780783641 @default.
- W4212873892 hasConceptScore W4212873892C2781231385 @default.
- W4212873892 hasConceptScore W4212873892C28781525 @default.
- W4212873892 hasConceptScore W4212873892C31903555 @default.
- W4212873892 hasConceptScore W4212873892C33070731 @default.
- W4212873892 hasConceptScore W4212873892C54355233 @default.
- W4212873892 hasConceptScore W4212873892C55493867 @default.
- W4212873892 hasConceptScore W4212873892C556039675 @default.
- W4212873892 hasConceptScore W4212873892C62112901 @default.
- W4212873892 hasConceptScore W4212873892C71924100 @default.
- W4212873892 hasConceptScore W4212873892C81885089 @default.
- W4212873892 hasConceptScore W4212873892C86803240 @default.
- W4212873892 hasLocation W42128738921 @default.
- W4212873892 hasOpenAccess W4212873892 @default.
- W4212873892 hasPrimaryLocation W42128738921 @default.
- W4212873892 hasRelatedWork W2349175154 @default.
- W4212873892 hasRelatedWork W2355034335 @default.
- W4212873892 hasRelatedWork W2358524133 @default.
- W4212873892 hasRelatedWork W2361020480 @default.
- W4212873892 hasRelatedWork W2362645172 @default.
- W4212873892 hasRelatedWork W2370855104 @default.
- W4212873892 hasRelatedWork W2372999700 @default.
- W4212873892 hasRelatedWork W2384155018 @default.
- W4212873892 hasRelatedWork W2588942881 @default.
- W4212873892 hasRelatedWork W3032871523 @default.
- W4212873892 isParatext "false" @default.
- W4212873892 isRetracted "false" @default.
- W4212873892 workType "article" @default.